BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2012
View Archived Issues
Eisai describes new clinical candidate for anxiety and depression
Read More
Novel nanotechnology targets t-PA to obstructed blood vessels
Read More
Novel DAAO inhibitor shows potential to treat schizophrenia
Read More
Small molecule shows potential for as a contraceptive for men
Read More
New DNA tests developed for hereditary diseases
Read More
Medivir moves MIV-711 into phase Ib testing
Read More
Orexo plans NDA for sublingual buprenorphine/naloxone product
Read More
Pluristem and BCRT renew 5-year collaboration
Read More
New phase III data disclosed on Inavir
Read More
Novel prosthetic incorporates retinal code to restore vision
Read More
NIH awards HIV vaccine research grants
Read More
Aurum Biosciences and Oxygen Biotherapeutics present novel Oxycyte data
Read More
Scientists at Novartis synthesize novel CDK9 inhibitors
Read More
Investigation at Sphaera Pharma yields new PI3K/mTOR inhibitors
Read More
Boehringer Ingelheim Pharma reports new SYK inhibitors
Read More
New pim-1/2 inhibitors developed
Read More
Novel tyrosine kinase inhibitors patented by Pierre Fabre Medicament
Read More
Glymera enters phase IIb trial for uncontrolled type 2 diabetes
Read More
FDA extends tofacitinib NDA PDUFA date
Read More
FDA to discuss Gattex NDA at advisory committee meeting
Read More
Vernalis kicks off receptor occupancy study of V-81444
Read More
Foundation Fighting Blindness to fund eight projects for retinal degenerative diseases
Read More
NICE issues new guidance on bevacizumab
Read More
VolitionRX and Belgian hospital sign agreement for prospective colon cancer trial
Read More
Research collaboration begins for delivery of microRNA-based therapeutics
Read More